Assessment of the inhibition risk of chlorophenol substances on cytochrome P450 via cocktail inhibition assays

Toxicol Appl Pharmacol. 2023 Feb 15:461:116401. doi: 10.1016/j.taap.2023.116401. Epub 2023 Jan 24.

Abstract

Chlorophenols (CPs) are widespread pollutants in nature. CPs have raised significant concern due to their potential hepatotoxic effects on humans. This research aimed to ascertain the inhibitory potential of eleven CPs (2-CP, 3-CP, 4-CP, 2,4-DCP, 2,3,4-TCP, 2,4,5-TCP, 2,4,6-TCP, 2,3,4,5-TeCP, 2,3,4,6-TeCP, 2,3,5,6-TeCP, and PCP) on nine human CYP isoforms (CYP1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, and 3A4). The CPs that inhibit the activity of CYP isoforms were detected with human liver microsomes (HLM) using a cocktail approach in vitro. The results demonstrated that trichlorophenols, tetrachlorophenols, and PCP strongly inhibited CYP2C8 and CYP2C9. The half inhibition concentration (IC50) value of 2,3,4,6-TeCP and PCP for CYP2C8 inhibition was 27.3 μM and 12.3 μM, respectively. The IC50 for the inhibition of 2,4,6-TCP, 2,3,4,6-TeCP and PCP towards CYP2C9 were calculated to be 30.3 μM, 5.8 μM and 2.2 μM, respectively. 2,3,4,6-TeCP, and PCP exhibited non-competitive inhibition towards CYP2C8. 2,4,6-TCP, 2,3,4,6-TeCP, and PCP exhibited competitive inhibition towards CYP2C9. The inhibition kinetics parameters (Ki) were 51.51 μM, 22.28 μM, 37.86 μM, 7.27 μM, 0.68 μM for 2,3,4,6-TeCP-CYP2C8, PCP-CYP2C8, 2,4,6-TCP-CYP2C9, 2,3,4,6-TeCP-CYP2C9, PCP-CYP2C9, respectively. This study also defined clear structure-activity relationships (SAR) of CPs on CYP2C8, supported by molecular docking studies. Overall, CPs were found to cause inhibitory effects on CYP isoforms in vitro, and this finding may provide a basis for CPs focused on CYP isoforms inhibition endpoints.

Keywords: Chlorophenols (CPs); Cytochrome P450 (CYP) isoforms; Inhibition; Structure-activity relationship (SAR).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chlorophenols* / toxicity
  • Cytochrome P-450 CYP2C8
  • Cytochrome P-450 CYP2C9 / pharmacology
  • Cytochrome P-450 Enzyme Inhibitors* / toxicity
  • Cytochrome P-450 Enzyme System
  • Humans
  • Microsomes, Liver
  • Molecular Docking Simulation

Substances

  • Cytochrome P-450 CYP2C8
  • Cytochrome P-450 CYP2C9
  • Cytochrome P-450 Enzyme Inhibitors
  • Cytochrome P-450 Enzyme System
  • Chlorophenols